Frontal fibrosing alopecia. Cicatricial alopecia, unspecified
Conditions
Interventions
Intervention 1: A group of 15 patients are treated with finasteride tablets of 2.5 mg daily for 6 months. Intervention 2: Intervention group: A group of 15 patients treated with hydroxychloroquine 400
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: New cases with FFA who have not yet received any medication. Patients who have previously received systemic therapy and have not received systemic medication for at least the last three months and according to clinical and dermoscopic criteria, their disease is active. Patients treated with topical medication and according to clinical and dermoscopic criteria, their disease is active
Exclusion criteria
Exclusion criteria: Pregnancy or lactation History of hypersensivity due to hydroxychloroquine or finasteride Patients with severe blood dyscrasia and liver dysfunction Patients with retinopathy Personal history or family history of breast cancer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frontal fibrosing alopecia severity index. Timepoint: Before and after intervention. Method of measurement: Checklist.;Standardized global photography. Timepoint: Before and after intervention. Method of measurement: Based on scoring by two dermatologist.;Tricoscopy. Timepoint: Before and after intervention. Method of measurement: Based on scoring by two dermatologist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Farokhshah
Esfahan University of Medical Sciences
Outcome results
None listed